Subject: Triggering receptor expressed on myeloid cells − 1 (Trem-1) | RB1-214 | Pathology | Histology | Pattern recognition receptors (PRR) | Pathology and Forensic Medicine | Hyporesponsiveness | Neutrophils | Endotoxin tolerance | Research | Sepsis
<p>Abstract</p> <p>Background</p> <p>Bacterial sepsis induced immunsuppression via antigen hyporesponsibility increases the risk of nosokomial infections and mortality. Pattern recognition receptors (PRR) might have a central role in the pathophysiology of hyporesponsib... View more
2. Manthey CL, Vogel SN: Interactions of lipopolysaccharide with macrophages. Immunol Ser 1994, 60:63-81.
3. Sessler CN, Bloomfield GL, Fowler AA: Current concepts of sepsis and acute lung injury. Clin Chest Med 1996, 12:213-235.
4. Munford RS, Pugin J: Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med 2001, 163:316-321.
5. West MA, Heagy W: Endotoxin tolerance: a review. CritCare Med 2002, 30(1 Suppl.):S64-S73.
6. Härter L, Mica L, Stocker R, Trentz O, Keel M: Increased expression of tolllike receptor-2 and −4 on leukocytes from patients wit sepsis. Shock 2004, 22:403-409.
7. Lehner MD, Morath S, Michelsen KS, Schumann RR, Hartung T: Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different Toll-like receptors independent of paracrine mediators. J Immunol 2001, 166:5161-5167.
8. Nomura F, Akashi S, Sakao Y, Sato S, Kawai T, Matsumoto M, Nakanishi K, Kimoto M, Miyake K, Takeda K, Akira S: Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with downregulation of surface toll-like receptor 4 expression. J Immunol 2000, 164:3476-3479.
9. Oku R, Oda S, Nakada TA, Sadahiro T, Nakamura M, Hirayama Y, Abe R, Tateishi Y, Ito M, Iseki T, Hirasawa H: Differential pattern of cell-surface and soluble TREM-1 between sepsis and SIRS. Cytokine 2013, 61:112-117.
10. Uehara A, Sato T, Iwashiro A, Yokota S: PR3-ANCA in Wegener's granulomatosis prime human mononuclear cells for enhanced activation via TLRs and NOD1/2. Diagn Pathol 2009, 4:23.